EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bedaquiline Resistance: A Looming Global Threat in Tuberculosis Management

Indu Singh, Juhi Sharma, Divakar Sharma, Arun Ratn, Deepa Bisht, Sandeep Sharma, Megh Singh Dhakad, Jasbir Dalal, Mirza Masroor Ali Beg

Current Microbiology · 2026-01 · 83 (1)

DOI: 10.1007/s00284-025-04655-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Microbiology, online erschienen am 09.12.2025. Verfasst von Indu Singh und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Graphic Era Hill University, Dehradun, 248002, India. Hauptthemen laut MEDLINE: Diarylquinolines, Antitubercular Agents, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 96 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of bedaquiline holds promise for treating multidrug-resistant tuberculosis (MDR-TB). Still, the inflation in bedaquiline resistance has alarmed the global public health crisis, indicating the need for a new treatment strategy. Several scientific studies have reported a high incidence of resistance among MDR-TB patients who had prior exposure to bedaquiline for treating Mycobacterium tuberculosis infections. Disparate research findings indicate that individuals previously administered this drug exhibit a remarkable prevalence of resistance. Studies have further demonstrated that prior treatment often correlates with the emergence of resistant Mycobacterium tuberculosis strains. Overall, evidence from multiple investigations highlights a concerning trend of increased resistance in MDR-TB cases with a history of bedaquiline therapy. Moreover, bedaquiline resistance in MDR-TB strains has been linked to mutations in several chromosomal genes, including atpE, Rv0677c, Rv0678, and pepQ. Consequently, it is imperative to mitigate the burden of MDR-TB and bedaquiline resistance. Herein, this article emphasizes structural features, mechanism of action, emergence of underlying resistance mechanisms, pharmacokinetic & pharmacodynamic properties, clinical toxicity, and strategies to combat resistance associated with bedaquiline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiarylquinolinesAntitubercular AgentsMycobacterium tuberculosisTuberculosis, Multidrug-ResistantDrug Resistance, Multiple, BacterialHumansGlobal Health

Substanzen

bedaquilineDiarylquinolinesAntitubercular Agents

Autor:innen und Institutionen

  • School of Pharmacy, Graphic Era Hill University, Dehradun, 248002, India.
  • Department of Biotechnology, Graphic Era (Deemed to be) University, Dehradun, 248002, India.
  • School of Life Science, Jaipur National University, Jaipur, India.
  • Department of Biotechnology, Graphic Era (Deemed to be) University, Dehradun, 248002, India. divakarsharma88@gmail.com.
  • Department of Zoology, Sanatan Dharm College, Muzaffarnagar, 251001, India.
  • Department of Biochemistry, ICMR-National JALMA Institute for Leprosy and other Mycobacterial Diseases, Tajganj, Agra, India.

Zitieren

APA

Singh, I., Sharma, J., Sharma, D., Ratn, A., Bisht, D., Sharma, S., Dhakad, M. S., Dalal, J., & Beg, M. M. A. (2026). Bedaquiline Resistance: A Looming Global Threat in Tuberculosis Management. Current Microbiology, 83(1). https://doi.org/10.1007/s00284-025-04655-7

Vancouver

Singh I, Sharma J, Sharma D, Ratn A, Bisht D, Sharma S, et al. Bedaquiline Resistance: A Looming Global Threat in Tuberculosis Management. Current Microbiology. 2026;83(1). doi:10.1007/s00284-025-04655-7

BibTeX
@article{Singh2026,
  author = {Singh, Indu and Sharma, Juhi and Sharma, Divakar and Ratn, Arun and Bisht, Deepa and Sharma, Sandeep and Dhakad, Megh Singh and Dalal, Jasbir and Beg, Mirza Masroor Ali},
  title = {Bedaquiline Resistance: A Looming Global Threat in Tuberculosis Management},
  journal = {Current Microbiology},
  year = {2026},
  volume = {83},
  number = {1},
  doi = {10.1007/s00284-025-04655-7}
}
Kostenlos starten →